General Information
Basic Resources from Various Sites:
- Hepatitis B (MedlinePlus)
- What I need to know about hepatitis B (National Institute of Diabetes and Digestive and Kidney Diseases) and Spanish version
- Hepatitis A, B & C (Avert)
- Towards a healthy liver (Project Inform) and Spanish version
- Blood Safety (CDC) – includes information about screening blood for HIV, viral hepatitis, and other disease organisms
Resources from CDC:
- Frequently Asked Questions (FAQs) for the Public
- FAQs for Health Professionals
- Hepatitis B vaccine: What you need to know
- The ABCs of Hepatitis
Resources from the HBV and HCV Advocate:
- A Guide to Hepatitis B
- When Is Treatment [for Hepatitis B] Needed?
- Hepatitis B and Other Medical Conditions
- Hepatitis Glossary
- Links to Organizations and Resources
Resources from the Hepatitis B Foundation:
- Hepatitis B Patient Information Booklet
- ABC’s of Viral Hepatitis
- Hepatitis B Virus
- Transmission
- Symptoms
- Acute vs. Chronic Hepatitis B
- Your Liver and Its Functions
- Donating Blood
- Glossary
- Adults and HBV
- Pregnancy and HBV
- Children and HBV
- Approved Drugs for Adults
- Who Should Be Treated
- Approved Drugs for Children
- Hepatitis B Clinical Trials
- Hepatitis B Foundation Drug Watch
- Prevention Measures
- Hepatitis B Vaccine
- Hepatitis B Vaccine General Recommendations
- Vaccine Non-Responders
- Post-Exposure Treatment
- Hepatitis A Vaccine
- Hepatitis B Foundation Vaccine Watch
Guidelines
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (CDC, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America)
- Hepatitis B Revaccination Effective in People with HIV (January 2008, Poz)
Selected Recent Articles
- Aflatoxin Alert: Moldy Nuts and Corn Increases Your Liver Cancer Risk 60-Times If You Have Hepatitis B. (October 2016, Hepmag)
- Nutrition and Exercise and Hepatitis B. (September 2016, Hepmag)
- Addition of PEG-IFN to ART does not improve hepatitis B clearance rates. (September 2016, Healio)
- HIV Meds Haven’t Prevented End-Stage Liver Disease in Those with Hepatitis. (September 2016, Poz)
- New Guidelines Recommend Hep B Testing Before Hep C Treatment. (September 2016, Hepmag)
- Maine’s Heroin Crisis Leads to Major Rise in Hepatitis B. (September 2016, Hepmag)
- People with Hepatitis B Often Lack Proper Care. (August 2016, Hepmag)
- FDA Updates Blood Donor Screening Guidelines to Help Prevent Hepatitis B Transmission. (August 2016, Hepmag)
- Many people in the U.S. with chronic hepatitis B not being properly monitored. (August 2016, AIDSmap)
- Ongoing hepatitis B virus replication associated with higher mortality for people with HIV. (August 2016, AIDSmap)
- World Health Organization Contest Seeks New Solutions for Hepatitis Testing. (July 2016, Hepmag)
- Baraclude (Entecavir) Lowers Liver Cancer Risk in People with Hepatitis B. (July 2016, Hepmag)
- Is a Cure for Hepatitis B Coming? Experts Say Yes. (June 2016, Hepmag)
- HBV/HIV coinfection leads to poorer outcomes in hospitalized patients. (June 2016, Healio)
- New HBV drugs and non-viral liver disease in HIV positive people. (June 2016, HIV Treatment Bulletin)
- Seattle Hospital Warns 650 Dialysis Patients of Possible Hepatitis B Exposure. (June 2016, Hepmag)
- New York City Reports Extremely High Hepatitis B Rates in Parts of Brooklyn and Queens. (June 2016, Hepmag)
- People With Hepatitis B May Not Respond As Well to Starting HIV Treatment. (June 2016, Hepmag)
- HIV/HBV co-infection linked to worse immune recovery and death, but tenofovir improves outcomes. (May 2016, AIDSmap)
- High-dose HBV vaccine improves HIV patients’ long-term immune response. (May 2016, Healio)
- New Documentary Examines Hepatitis B Among Asian Americans. (April 2016, Hepmag)
- New Tenofovir Is As Good As, Safer Than Old Version for Hepatitis B. (April 2016, Hepmag)
- Ending the U.S. Epidemics of Hepatitis B and Hepatitis C Is Now Feasible. (April 2016, Hepmag); related coverage from Hepmag
- Hepatitis B Prevalence High Among Syrian Refugees in Europe. (April 2016, Hepmag)
- Tenofovir alafenamide works well against hepatitis B with less effect on bones and kidneys. (April 2016, AIDSmap)
- Eliminating Hepatitis B & C is Feasible, But What Will it Take to Achieve this Goal? (April 2016, NASTAD)
- Help Stop Insurers from Over-Charging Patients for Hepatitis B Drugs on the Healthcare Marketplace. (April 2016, Hepmag)
- ContraVir’s Hep B Treatment Beats Gilead’s New Tenofovir in Lab Tests. (April 2016, Hepmag)
- Liver Cancer Death Rate Increasing Faster Than All Other Cancers; Implementation of Viral Hepatitis Action Plan Urgently Needed. (March 2016, Hepmag)
- Opt-out HIV/HBV/HCV testing for patients attending emergency departments identifies significant number of new infections. (March 2016, AIDSmap)
- CDC Statement on Liver Cancer and Hepatitis. (March 2016, Project Inform); related coverage from Hepmag
- Institute of Medicine Expert Committee Assessing Feasibility of Viral Hepatitis Elimination Targets in the U.S. (March 2016, Hepmag)
- HCV, HBV, alcohol use associated with ESLD in patients with HIV. (February 2016, Healio)
- For Hep B, New Viread Proves as Effective, Safer Than Old Version. (January 2016, Hepmag)
- Most U.S. States Not Prepared for Infectious Disease Outbreaks. (December 2015, Hepmag)
- Less Liver Fibrosis for Coffee Drinkers with Hep B or C. (November 2015, Hepmag)
- People With Hep B Have Raised Risk of Only Liver. (November 2015, Hepmag)
- Tenofovir during pregnancy reduces risk of mother-to-child hepatitis B virus transmission. (November 2015, AIDSmap)
- Promising Results for REP 2139 Treating Hep B and D Coinfection. (November 2015, Hepmag)
- REP 2139 shows promise for people with hepatitis B and hepatitis delta co-infection. (November 2015, AIDSmap)
- Identifying Strategies to Eliminate Perinatal Hepatitis B Transmission. (October 2015, Hepmag)
- HIV Treatment Can Significantly Lower Risk of Hepatitis B in HIV-Positive MSM. (October 2015, TheBodyPro.
- Successful HIV Treatment Protects Gay and Bi Men Against Hep B. (October 2015, Hepmag)
- Origin of Hepatitis B Perhaps in the Genes of Freshwater Fish. (October 2015, Hepmag)
- Global Trials Start For Cuba’s Promising Hepatitis B Drug. (August 2015, Hepmag)
- Are HIV Docs Testing Enough for Hep B-Linked Liver Cancer? (August 2015, Hepmag)
- After Hepatitis C, Gilead Seeks to Cure HIV and Hepatitis B. (August 2015, Hepmag)
- People with HIV and hepatitis B co-infection can safely switch to simpler TAF single-tablet regimen. (August 2015, AIDSmap)
- PrEP Is Safe for People With Hepatitis B. (August 2015, Poz)
- People with hepatitis B can safely use Truvada PrEP for HIV prevention. (August 2015, AIDSmap)
- Australian Hepatitis B Subtype Is 53,000 Years Old. (August 2015, Hepmag)
- In Those With HIV, Best to Treat Hep B With Two Drugs. (July 2015, Hepmag)
- Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection. (July 2015, AIDSmap)
- New Viral Hepatitis Numbers from the CDC. (June 2015, Hepmag)
- Hep C Worsens Progression of Hep B Disease. (June 2015, Hepmag)
- Hep B Vaccine Works Poorly in Those With Rheumatoid Arthritis. (June 2015, Poz)
- Hepatitis B and C co-infection linked to worse liver fibrosis than hepatitis B alone. (June 2015, AIDSmap)
- Early Study of Hepatitis B Immune Therapy Raises Cure Hopes. (May 2015, Hepmag)
- Eliminating Hepatitis B in the United States – Mothers Matter! (May 2015, Hepmag)
- New Hep B Partnership Between UPenn and Blumberg Institute. (May 2015, Hepmag)
- Could a Cancer Drug Cure Hepatitis B? (May 2015, Hepmag)
- Global Hep B Could Plummet With More Vaccination and Treatment. (May 2015, Hepmag)
- Expanded vaccination and treatment could help eliminate hepatitis B worldwide. (April 2015, AIDSmap)
- Yearly Cost to Treat Global Hepatitis B Could Be Only $36 Per Person. (April 2015, Hepmag)
- West Virginia Faces Epidemics of Hepatitis B and Hepatitis C. (April 2015, Hepmag)
- Babies With HBV-Positive Mothers May Have Better Immune Systems. (April 2015, Hepmag)
- Global hepatitis B epidemic treatable at cost of just $36 per patient per year. (April 2015, AIDSmap)
- Oral Hepatitis B Vaccine Made From GMO Corn Shows Promise. (April 2015, Hepmag)
- World Health Organization Issues Hepatitis B Guidelines. (March 2015, Hepmag)
- Former Gilead Executives Compete to Cure Hepatitis B. (February 2015, Hepmag)
- Experimental siRNA therapy lowers HBsAg levels in people with hepatitis B. (January 2015, Poz)
- Entecavir and tenofovir work well for people with drug-resistant hepatitis B virus. (December 2014, AIDSmap)
- Viread Effectively Combats Hepatitis B for at Least 8 Years. (December 2014, Hepmag)
- Genetically Engineered Corn Used for New Hepatitis B Vaccine. (November 2014, Hepmag)
- Tenofovir continues to suppress hepatitis B virus for eight years. (November 2014, AIDSmap)
- Interferon Raises Chance of HBsAg Loss in People With Hepatitis B. (November 2014, Hepmag)
- Safety Concerns Cited Against Hepatitis B Vaccine for Infants. (November 2014, Hepmag)
- Adding pegylated interferon to tenofovir improves odds of HBsAg loss in hepatitis B patients. (November 2014, AIDSmap)
- Hepatitis B and NASH Next for Drug Makers After Hepatitis C Successes. (November 2014 for Hepmag)
- Hepatitis B testing and treatment rates are low among US veterans. (November 2014, AIDSmap)
- U.S. Vets Have Low Rates of Hep B Testing and Treatment. (November 2014 for Hepmag)
- Priority for Liver Cancer Tests Should Go to Hep B-Positive Cirrhotics. (October 2014, Hepmag)
- People with hepatitis B who have cirrhosis should be prioritised for liver cancer screening. (October 2014, AIDSmap)
- WHO Report: Nearly Half of Global Hepatitis B Is in Western Pacific. (August 2014, Hepmag)
- Isis, GSK Sign $1M Deal to Develop New Hep B Drugs. (July 2014, Hepmag)
- Task Force Recommends Hep B Tests For Those At Risk. (June 2014, Poz)
- Adding interferon to nucleoside antivirals may improve response for people with chronic hepatitis B. (April 2014, AIDSmap)
- Gay Men, IDUs and People With HIV Should Test for Hep B. (February 2014, Poz)
- China Suspends Hepatitis B Vaccines After 2 Fatalities. (December 2013, Poz)
- Entecavir + tenofovir works well for people with hepatitis B who have had prior treatment failure. (November 2013, AIDSmap)
- Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk. (November 2013, AIDSmap)
- HIV/Hep B Coinfection Responds Very Well to Viread. (September 2013, Poz)
- Tenofovir is highly effective for HIV/HBV co-infection, meta-analysis shows. (September 2013, AIDSmap)
- Hep B or C Coinfection Spells Worse Response to HIV Meds. (July 2013, Poz)
- Experts discuss role of drug policy in HIV, hepatitis and TB epidemics. (July 2013, AIDSmap)
- Hyaluronic acid levels can predict risk of serious liver events in people living with HIV and hepatitis B or C co-infection. (June 2013, AIDSmap)
- Combo of 2 HIV Drugs Can Control Hepatitis B. (May 2013, Poz)
- Viread and Epivir Lower Risk of Hepatitis B Infection in HIV-Positive Gay Men. (April 2013, Poz)
- Tenofovir and 3TC prevent new hepatitis B infections in gay men living with HIV. (April 2013, AIDSmap)
- Drinking coffee halves the risk of liver cancer. (April 2013, AIDSmap)
- Dually active antiretroviral therapy protects against hepatitis B infection. (March 2013, AIDSmap)
- Triple trouble: infection with hepatitis B increases risk of death for people with HIV and hepatitis C co-infection. (February 2013, AIDSmap)
- Combining tenofovir with FTC or 3TC boosts chances of HBV suppression for people co-infected with HIV. (February 2013, AIDSmap)
- Co-infection with hepatitis B or C is a risk factor for reduced bone mineral density among women with HIV. (January 2013, AIDSmap)
- Hepatitis B treatment and care in the UK need to evolve to keep pace with the global epidemic. (January 2013, AIDSmap)